Retraction notice to “Use of ivermectin in the treatment of Covid-19: A pilot trial” [Toxicol. Rep. 8 (2021) 505–510] (Toxicology Reports (2021) 8 (505–510), (S2214750021000445), (10.1016/j.toxrep.2021.03.003))

Henrique Pott-Junior, Mônica Maria Bastos Paoliello, Alice de Queiroz Constantino Miguel, Anderson Ferreira da Cunha, Caio Cesar de Melo Freire, Fábio Fernandes Neves, Lucimar Retto da Silva de Avó, Meliza Goi Roscani, Sigrid De Sousa dos Santos, Silvana Gama Florêncio Chach´

Research output: Contribution to journal › Comment/debate › peer-review

Fingerprint

Dive into the research topics of 'Retraction notice to “Use of ivermectin in the treatment of Covid-19: A pilot trial” [Toxicol. Rep. 8 (2021) 505–510] (Toxicology Reports (2021) 8 (505–510), (S2214750021000445), (10.1016/j.toxrep.2021.03.003))'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds